THEOFAN GEORGIA 4
4 · IMMUNE RESPONSE CORP · Filed Aug 10, 2005
Insider Transaction Report
Form 4
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Award
Common Stock
2005-06-30$0.65/sh+5,385$3,500→ 24,240 total
Footnotes (1)
- [F1]Matching company contribution to 401K account.